A study published in the Journal of Applied Ecology revealed when, where and how most songbirds migrate offshore over North ...

The ongoing math wars plus persistent teacher pipeline issues are among the most powerful forces behind students’ ...

The Associated Press analyzed data from the Stanford Education Data Archive and found that in the decade before the pandemic, girls had not only improved math scores nationwide, but they were also ...

What retirees think of Donald Trump's 401(k) changes Barr’s Account of Epstein Footage Raises Questions Bear attack in Florida caught on doorbell camera, watch the video Helen Mirren feels ‘insulted’ ...

CAL101 is a first-in-class monoclonal antibody targeting S100A4, a damage-associated molecular pattern (DAMP) protein associated with serious and life-threatening fibrotic disorders Phase 2 AURORA ...

Fewer Americans are opening a book for fun each day, with reading for pleasure in the U.S. down 40% over the past 20 years, a ...

Emmanuel Macron Reacts To Trump's Hot Mic Comment On Vladimir Putin A Massive New Study Says This Is What Happens to People Who Drink Black Coffee Every Day Amazon recall update nationwide as ...

Reunion Neuroscience’s psychedelic has reduced the symptoms of postpartum depression in a phase 2 study, setting up the biotech to launch a late-stage trial next year. The drug in question is RE104, a ...

PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...

Primary Endpoint met: Statistically significant reduction in blood-fat levels after eating (-51.9%) Multiple secondary endpoints met: Including statistically significant reduction in weight regain ...

Per- and polyfluoroalkyl substances (PFAS) exposure is linked to a 31% increased risk of type 2 diabetes (T2D), with perfluorooctane sulfonate being a significant contributor. Metabolomic profiling ...

Sellas Life Sciences’ investigational CDK9 inhibitor has scored in a midstage acute myeloid leukemia (AML) study, demonstrating an overall response rate (ORR) more than double the 20% goal. The ...